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ABSTRACT
Telomere integrity in human cells is maintained by
the dynamic interplay between telomerase, telo-
mere associated proteins, and DNA repair proteins.
These interactions are vital to suppress DNA
damage responses and unfavorable changes in
chromosome dynamics. The DNA-dependent pro-
tein kinase (DNA-PK) is critical for this process.
Cells deficient for functional DNA-PKcs show
increased rates of telomere loss, accompanied by
chromosomal fusions and translocations. Treat-
ment of cells with specific DNA-PK kinase inhibitors
leads to similar phenotypes. These observations
indicate that the kinase activity of DNA-PK is
required for its function at telomeres possibly
through phosphorylation of essential proteins
needed for telomere length maintenance. Here we
show that the heterogeneous nuclear ribonucleo-
protein A1 (hnRNP A1) is a direct substrate for
DNA-PK in vitro. Phosphorylation of hnRNP A1 is
stimulated not only by the presence of DNA but
also by the telomerase RNA component, hTR.
Furthermore, we show that hnRNP A1 is phos-
phorylated in vivo in a DNA-PK-dependent manner
and that this phosphorylation is greatly reduced in
cell lines which lack hTR. These data are the first
to report that hTR stimulates the kinase activity of
DNA-PK toward a known telomere-associated
protein, and may provide further insights into the
function of DNA-PK at telomeres.
INTRODUCTION
Telomeres are tandem repeats of short DNA sequences
(TTAGGG in humans) at the ends of linear
chromosomes. In humans, the telomerase holoenzyme,
minimally composed of the reverse transcriptase,
hTERT, and an RNA component, hTR, is responsible
for synthesizing telomeric repeats during DNA repli-
cation. hTERT utilizes hTR as a template to add the
repeats onto the 30 ends of chromosomes (1–3). In add-
ition to its role as a polymerase, telomerase cooperates
with members of the Shelterin protein complex to estab-
lish a protective nucleoprotein ‘cap’ for chromosome
termini (4). Maintenance of this cap is necessary to protect
telomeres from cellular DNA damage responses that
can disrupt chromosome dynamics; this in turn can
result in aneuploidy and/or aberrant fusion events that
may result in cellular transformation. Paradoxically,
many of the proteins found at the telomere are also crit-
ical for the repair of DNA double-strand breaks (DSBs).
One such protein is the DNA-dependent protein kinase
(DNA-PK).
DNA-PK is composed of a DNA-binding subunit,
Ku70/80 and a catalytic subunit (DNA-PKcs). This holo-
enzyme is required for the repair of DSBs via the non-
homologous end-joining (NHEJ) pathway (5,6). Current
models for NHEJ propose that the Ku heterodimer
binds to exposed ends of double stranded (ds)DNA and
serves as the signal to recruit DNA-PKcs to establish
the active DNA-bound DNA-PK complex. DNA-PK is
a serine-threonine protein kinase that phosphorylates
its substrates predominantly on serines or threonines
that are followed by glutamine (SQ/TQ motifs) (5,7).
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Ku and DNA-PKcs itself (5). Cells deﬁcient for functional
DNA-PKcs show high levels of chromosome end-to-end
fusions due to chromosome uncapping and telomere
dysfunction (8–10). Moreover, mouse cells deﬁcient for
both DNA-PKcs and Terc (mouse TR) exhibit accelerated
rates of telomere shortening compared to cells solely
deﬁcient for Terc, suggesting a functional interaction
between DNA-PKcs and telomerase in sustaining telo-
mere length and function (11). Similarly, mouse cells
lacking wild type Ku70 or Ku80 display a higher rate of
chromosomal end-to-end fusions due to loss of telomere
end-capping function, without any signiﬁcant decrease
in telomere length (8–10). However, in mouse cells that
lack both DNA-PKcs and the telomerase RNA, both telo-
mere shortening and telomere dysfunction are observed, in
contrast to cells which lack only DNA-PKcs where telo-
mere length is sustained (11). Additionally, in mouse cells,
Ku70/80 associates with telomeric DNA (12), and
interacts with the core proteins of the Shelterin complex,
namely TRF1 and TRF2 (13,14). Moreover, Ku has been
reported to associate with hTERT (15). Interestingly,
treatment of mouse cells with speciﬁc DNA-PK inhibitors
also leads to increased rates of end-to-end fusions (16).
Together, these data support a role for DNA-PK in telo-
mere function, both in end-capping and in maintenance of
telomere length. However, the precise biochemical func-
tion and mechanism of action of DNA-PK at telomeres
remains unknown (9,10).
We have previously shown that human Ku70/80
interacts with the human telomerase RNA component,
hTR (17). Moreover, the interaction between Ku70/80
and telomerase RNA (TLC1) is also observed in yeast
(18). Speciﬁcally, Saccharomyces cerevisiae strains
harboring either TLC1 that lacks the stem loop region
for yKu binding (Tlc1D48), or Ku alleles that do not inter-
act with TLC1 (yKu80-135i), show decreased rates of telo-
mere synthesis (18). The yKu70/80/TLC1 interaction is
required for proper recruitment of yeast telomerase to
the chromosome end for telomere synthesis in late S-
phase (19). Yeast, however, do not contain DNA-PKcs,
suggesting that the interaction and regulation of telomer-
ase with DNA-PK in human cells is more complex.
It is becoming clear that phosphorylation regulates
the function of many proteins that are involved in the
regulation of telomere length. In yeast, phosphorylation
of the single strand telomere binding protein Cdc13 by
Tel1 and Mec1 (the yeast homologues of human ATM
and ATR, respectively) modulates its interaction with
Est1p and facilitates telomerase recruitment (20). In
human cells, TRF2 is phosphorylated by ATM in
response to DNA damage and the phosphorylated form
of the protein does not interact with telomeric DNA (21).
Similarly, TRF1 is phosphorylated by ATM in an
Nbs1-dependent manner, promoting its release from
the telomere (22). These data indicate that protein
phosphorylation is a critical regulatory mechanism for
proteins involved in telomere length maintenance. Since
inhibition of the kinase activity of DNA-PK results in
telomere dysfunction (16), we speculate that DNA-PK
phosphorylates speciﬁc telomere or telomerase-associated
proteins, thereby regulating their function at the telomere.
One interesting protein that has been shown to func-
tion in telomere length maintenance is hnRNP A1.
hnRNP A1 is a member of the hnRNP A/B family.
Members of the hnRNP family (including hnRNP A1)
are involved in a variety of RNA-related processes such
as alternative splicing, mRNA maturation/turnover,
mRNA transport and telomere and telomerase regulation
(23). The hnRNP A/B family includes hnRNP A1, A2 and
A3, each of which is alternatively spliced. These proteins
contain two N-terminal RNA recognition motifs (RRMs)
and a glycine rich domain at the C-terminus (23). There
is strong evidence that hnRNP A1 plays a critical role
in telomere biogenesis. First, hnRNP A1 and its proteo-
lytic fragment Unwinding Protein 1 (UP1) (24), bind telo-
meric DNA in a sequence speciﬁc manner in vitro (25).
Second, a murine erythroleukemic cell line deﬁcient for
hnRNP A1 has shortened telomeres, and reintroduction
of hnRNP A1 into these cells overcomes this phenotype
(25). Third, a UP1 containing complex assembles on
telomeric DNA oligonucleotides in nuclear extracts
and recombinant UP1 interacts with telomerase in mam-
malian cell extracts (26). Fourth, the ﬁrst RRM motif of
hnRNP A1 interacts with telomeric DNA in vitro (26),
while simultaneously the second RRM motif interacts
with the telomerase RNA (27). And ﬁnally, it has been
proposed that hnRNP A1 contributes to telomere elong-
ation by unwinding G-quadruplexes that form during
telomere elongation (28). This evidence suggests a critical
function for hnRNP A1 in telomere length maintenance,
possibly by facilitating recruitment of telomerase to
chromosome ends or modulating higher order telomere
structures.
hnRNP A1 is known to undergo a number of post-
translational modiﬁcations, including sumoylation (29),
methylation (30–33) and phosphorylation (34–37), and
each modiﬁcation is reported to aﬀect its nucleic acid
binding properties. Although phosphorylation of
hnRNP A1 has been shown to aﬀect the splicing activities
of hnRNP A1, little is known about whether post-
translational modiﬁcations are required for its role in
telomere maintenance.
To further elucidate the biological signiﬁcance of our
previous observation that Ku interacts with hTR in
human cells (17), we asked whether the interaction of
Ku with hTR can establish an active DNA-PK
holoenzyme. Here, we show that like DNA, hTR
promotes phosphorylation of hnRNP A1 by DNA-PK
in vitro. Moreover, hnRNP A1 interacts with Ku in a
cellular context, and we have identiﬁed a novel phosphor-
ylation site on hnRNP A1 that is targeted by DNA-PK
in vitro. Furthermore, inhibition of DNA-PK reduced
phosphorylation of hnRNP A1 in vivo and the phosphor-
ylation of hnRNP A1 was greatly decreased in cells
lacking hTR. To our knowledge, this is the ﬁrst report
indicating that hnRNP A1 is a direct DNA-PK substrate,
and that the telomerase RNA, a speciﬁc structured and
biologically active RNA molecule, can stimulate the pro-
tein kinase activity of DNA-PK.
6106 Nucleic Acids Research, 2009, Vol. 37,No. 18MATERIALS AND METHODS
Kinase assays
DNA-PKcs and Ku70/80 were puriﬁed from HeLa cells as
previously described (38). GST-hnRNP A1 and GST-
hnRNP A2 were expressed in Escherichia coli BL21
strain and puriﬁed using glutathione-sepharose beads as
previously described (27). GST-XRCC4 and GST-Artemis
were expressed in bacteria and puriﬁed as described pre-
viously (38,39). All kinase reactions were performed
with 0.1mg of DNA-PKcs, 0.05mg of Ku and 1.0mgo f
protein substrate to be tested in the presence of 0.5mg
calf thymus (CT) DNA (or 0.5mg of hTR or the indicated
nucleic acids), 100mM NaCl, 25mM Tris–HCl pH 7.5,
10mM MgCl2, 1mM DTT, 0.1mM EDTA and
0.25mM ATP containing 1mCi
32P-g-ATP. Final reaction
volumes were 20mL. The reactions were incubated at 308C
for 10min, stopped with SDS sample buﬀer and frac-
tionated on SDS-PAGE. The gels were stained with
Coomassie blue, dried and analyzed by autoradiography.
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSA) studies with
full-length hTR (FL-hTR) or an hTR fragment spanning
nucleotides 404–451 were carried out as previously
described (17). The amount of protein used in each experi-
ment is described in the ﬁgure legends. For western blot
analysis of the EMSA reactions, the non-denaturing gels
were transferred onto PVDF membrane under the previ-
ously described conditions (17). The blots were analyzed
with monoclonal antibodies to Ku70 and Ku80 (Ab5 and
Ab2, NeoMarkers) and hnRNP A1 (ImmuQuest, UK).
Immunoprecipitation and western analysis
For experiments exploring the interaction between
hnRNP A1 and Ku,  4 10
6 asynchronously growing
human embryonic kidney 293T cells were used for each
immunoprecipitation reaction. Cells were harvested,
pelleted and resuspended with 5  the pellet volume
using CHAPS lysis buﬀer [100mM NaCl, 10mM Tris
pH 7.5, 10% (w/v) glycerol, 1% CHAPS, 1mM MgCl2,
1mM DTT, CompleteMini EDTA free protease
inhibitors (Boehringer Mannheim), 1mM NaF, 100mM
sodium orthovanadate, 20mM b-glycerophosphate] for
30min on ice. The extracts were then centrifuged at
13000rpm for 20min at 48C, to obtain whole cell extracts
for immunoprecipitation experiments (40). Approximately
1mg of each antibody was pre-coupled to 20ml of a 50%
slurry of protein G sepharose beads by incubating for
1h at 48C on a rotator. Whole cell extracts were pre-
cleared with protein G sepharose and then added to
the antibody-coated beads; the mixtures were then sub-
jected to constant rotation for 4h at 48C. The subsequent
immune complexes were washed 3 times with CHAPS lysis
buﬀer and fractionated on SDS–PAGE for western ana-
lysis using the aforementioned antibodies.
In vivo phosphorylation
For in vivo labeling experiments in Figure 8A, HeLa cells
cultured in DMEM containing 5% fetal calf serum (FCS)
were incubated in phosphate-free DMEM (Invitrogen)
containing 5% FCS for 1.5h. Protein kinase inhibitors
(suspended in DMSO) or an equivalent volume of
DMSO were then added directly into the media, and the
cells were further incubated for an additional 1h before
the addition of 400m Curies of
32P inorganic phosphate
(10mCuries/ml, Perkin Elmer) per 2ml of media. The cells
were further cultured for 4h and then harvested for
immunoprecipitation for hnRNP A1 as described above.
Protein concentrations were determined by standard
Bradford assays (BioRad) using BSA as standard to
ensure equal amounts of total protein were used for
each immunoprecipitation reaction. Following the western
transfer, the PVDF membrane was exposed to ﬁlm to
determine
32P incorporation into hnRNP A1, before
being analyzed by western blotting.
For experiments in Figure 8B, HeLa and WI38-VA13
cells were mock transfected or transfected with control
plasmid, pU3-500, or plasmid expressing hTR,
pU3-hTR-500 (a kind gift from Kathleen Collins) (41),
using Fugene 6 according to the manufacturer’s guide.
Transfected cells were grown for 48h, and then subjected
to in vivo labeling in the presence of DMSO or the DNA-
PK inhibitor NU4771 as described above. Extracts were
prepared for immunoprecipitation for hnRNP A1. To
determine hTR levels, cell cultures treated the same way
were grown in parallel, but not exposed to
32P-inorganic
phosphate. The cells were then isolated and RNA extracts
were prepared for RT–PCR analysis for hTR as previ-
ously described (17).
Generation of hnRNP A1 clones
Vectors expressing GST-hnRNP A1 and GST-hnRNP A2
(in pGEX-4ET) were kind gifts from Dr Benoit Chabot
(University of Sherbrooke). The phosphorylation mutants
for GST-hnRNP A1 S95A and S95/192A were created by
a standard PCR strategy in the pGEX vector by using the
following primers. The GST-hnRNP A1 S95A mutant was
created ﬁrst with the primers: RNP-N: 50-CGGGATCCA
TGTCTAAGTCCGAGTCTCCC-30; RNP-R: 50-CCGCT
CGAGTTAGAACCTCCTGCCACTGC-30; S95A-N:
50-CTCAAGAGAAGATGCTCAGCGACCAGGTG
C-30 and S95A-C: 50-GCACCTGGTCGCTGAGCATCT
TCTCTTGAG-30. The GST-hnRNP A1 S95/192A
mutant was created in the GST-hnRNP A1 S95A
mutant with the primers RNP-N, RNP-R, and the fol-
lowing primers: S192A-N: 50-GTGCTTCATCCGCTCA
GAGAGGTCGC-30; S192A-C: 50-GCGACCTCTCTGA
GCGGATGAAGCAC-30.
RESULTS
DNA-PK phosphorylates hnRNP A1 in an hTR- and
DNA-dependent manner
Linear dsDNA with exposed termini is the most eﬀective
activator of DNA-PK activity in vitro. Association of Ku
with ends of dsDNA recruits DNA-PKcs to form the
active kinase holoenzyme, which can then undergo
autophosphorylation or target other protein or peptide
substrates (5). Although most studies suggest that the
Nucleic Acids Research, 2009,Vol.37, No. 18 6107major activator of DNA-PK is dsDNA, it has also been
reported that DNA-PK activity can be stimulated by a
variety of nucleic acids in vitro, including single stranded
DNA, and nicked closed circular DNA (42,43). Recently,
it has been reported that poly(G) RNA can stimulate
DNA-PK activity towards puriﬁed recombinant DNA
helicase II (NHD II) and hnRNP C (44). Immune
complexes that contain both hnRNP C and hnRNP A1
were phosphorylated with exogenously added DNA-PK
and treatment of this reaction with RNase A reduced
phosphorylation, suggesting that this phosphorylation
event was RNA dependent (44). We previously reported
that Ku70/80 interacts with hTR both in vivo and
in vitro (17), and therefore, we wanted to test whether
this interaction could stimulate the kinase activity of
DNA-PK. We ﬁrst examined the ability of hTR to stimu-
late autophosphorylation of the components of the
DNA-PK holoenzyme (DNA-PKcs, Ku70 and Ku80) as
well as a well-established DNA-PK peptide substrate
containing the SQE motif (7). Incubation of puriﬁed
DNA-PKcs and Ku70/80 with hTR did not support auto-
phosphorylation of the complex, whereas, as expected,
the addition of CT DNA did (Figure 1A). Similarly,
hTR did not support phosphorylation of the SQE peptide
(data not shown).
Since both hnRNP A1 and DNA-PK are involved in
telomere function, and members of the hnRNP family are
DNA-PK substrates, we sought to determine whether
hnRNP A1 was a direct substrate for DNA-PK. hnRNP
A1 contains two potential DNA-PK phosphorylation sites
at Serine 95 and Serine 192 (Figure 2). We also tested,
whether or not the closely related protein hnRNP A2
was a DNA-PK substrate. hnRNP A2 is redundant with
hnRNP A1 with respect to its splicing function, however,
unlike hnRNP A1, hnRNP A2 does not function in telo-
mere length maintenance (25). Furthermore, hnRNP A2
lacks the two SQ sites found in hnRNP A1 (Figure 2).
In vitro DNA-PK assays using recombinant GST-
hnRNP A1 or A2 puriﬁed from bacteria were performed
in the presence of either CT-DNA or hTR. As shown in
Figure 1B (lanes 5 and 6), DNA-PK phosphorylated re-
combinant GST-hnRNP A1 in the presence of either CT
DNA or hTR, but not TE buﬀer alone (lane 4). However,
the closely related protein, hnRNP A2 (GST fusion
protein) was not phosphorylated under either condition
(Figure 1B, lanes 8 and 9). Treatment of the kinase reac-
tion with RNase A abolished hTR-dependent phosphor-
ylation of hnRNP A1, but not its DNA-dependent
phosphorylation (Figure 1C, compare lanes 5 to 6).
Similarly, RNase A had no eﬀect on the DNA-dependent
phosphorylation of hnRNP A1 by DNA-PK (Figure 1C,
lane 3). These observations reveal a novel in vitro property
of DNA-PK: namely that it can be activated by hTR to
phosphorylate hnRNP A1.
Specificity of hnRNP A1 phosphorylation by DNA-PK
In vitro, DNA-PK phosphorylates a number of diﬀerent
proteins that are involved in NHEJ. Two of these
substrates are XRCC4 and Artemis (38,39). To test
whether hTR-stimulated phosphorylation was also
observed with these proteins, we repeated the in vitro
kinase assays with recombinant GST-Artemis or
GST-XRCC4 puriﬁed from bacteria. As can be seen in
Figure 3A, these proteins were not eﬃciently phos-
phorylated by DNA-PK in the presence of hTR, however,
as expected, they were robustly phosphorylated in the
presence of CT-DNA (compare lanes 1 to 2 and 3 to 4,
right panel). These data demonstrate that hTR-dependent
phosphorylation by DNA-PK is speciﬁc for hnRNP A1.
Nucleic acid specificity for hnRNP A1 phosphorylation
As mentioned earlier, poly(G) RNA can stimulate DNA-
PK activity in vitro, although the physiological relevance
of this observation remains unknown (44). To compare
the speciﬁcity of hTR-stimulated phosphorylation by
DNA-PK with that of other nucleic acids, puriﬁed
DNA-PKcs, Ku70/80 and GST-hnRNP A1 were
incubated under kinase reaction conditions with either
oligo(dT), poly(AU), poly(G) or tRNA. As seen in
Figure 3B, only hTR and CT DNA supported DNA-
PK-dependent phosphorylation of hnRNP A1. To
further conﬁrm that the hTR- and DNA-dependent phos-
phorylation of hnRNP A1 was indeed due to DNA-PK, a
speciﬁc DNA-PK inhibitor, NU4771 (45), was added to
the kinase reactions. As shown in Figure 3C, NU4771
inhibited phosphorylation of GST-hnRNP A1 by DNA-
PK in vitro (Figure 3C).
DNA-PK and hTR requirements for hnRNP
A1 phosphorylation
We have previously shown that Ku preferentially
associates with the region of hTR spanning nucleotides
404–451 (17). We next tested diﬀerent regions of hTR
for their ability to stimulate DNA-PK phosphorylation
of hnRNP A1. As seen in Figure 4A, only FL-hTR
supported DNA-PK phosphorylation of GST-hnRNP
A1 (compare lanes 4–7 to lane 3). We next tested whether
or not diﬀerent regions of hTR could recapitulate the
FL-hTR requirement for DNA-PK phosphorylation of
hnRNP A1 when the sequences were expressed on two
diﬀerent RNA molecules. As shown in Figure 4B,
equimolar amounts of two diﬀerent regions of hTR that
reconstituted FL-hTR, did not complement each other
to support hnRNP A1 phosphorylation by DNA-PK
(lanes 5 and 6). These data suggest that the active
DNA-PK holoenzyme may form a complex with hnRNP
A1 in cis on the same FL-hTR molecule (to be discussed
further, see Figure 6). Furthermore, FL-hTR in the native
conﬁrmation was required for phosphorylation, since
heat-denatured FL-hTR did not stimulate DNA-PK activ-
ity for hnRNP A1 (Figure 4C). In combination, these data
suggest that intact, FL-hTR that maintains its secondary
structure is required for stimulating the phosphorylation
of hnRNP A1 by DNA-PK.
Interaction of Ku and hnRNP A1
The data shown in Figure 4 suggests that both hnRNP A1
and Ku may bind to the same FL-hTR molecule and
form a nucleoprotein complex that is competent for phos-
phorylation by DNA-PKcs. To determine whether Ku
6108 Nucleic Acids Research, 2009, Vol. 37,No. 18and hnRNP A1 both interact with FL-hTR, we performed
EMSAs with radiolabeled FL-hTR and puriﬁed Ku
and/or GST-hnRNP A1. As seen in Figure 5A, upper
panel, hnRNP A1 or Ku alone formed nucleoprotein
complexes with FL-hTR that migrate at a diﬀerent
position on the non-denaturing gel (Figure 5, top panel,
compare complex ‘a’ to ‘b’ in lanes 2 and 3 versus lanes
4 and 5). In the presence of both Ku and hnRNP A1, a
new slower ribonucleoprotein complex was formed
(indicated by complex ‘c’), suggesting that Ku and
hnRNP A1 may bind to the same FL-hTR molecule.
Previous studies have shown that hnRNP A1 interacts
with the ﬁrst 208 nucleotides of hTR (27), and Ku prefer-
entially associates with the 30 end of hTR constituting
nucleotides 404–451 (17). Consistently, in EMSA studies
with the 30 end of hTR, spanning nucleotides 404–451,
only a Ku–hTR complex was observed, but no hnRNP
A1–hTR complex was formed (Figure 5A, lower panel).
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Figure 1. hnRNP A1 is phosphorylated by DNA-PK in vitro in a DNA- and hTR-dependent manner. (A) Autophosphorylation of DNA-PK is not
supported by hTR. Puriﬁed DNA-PKcs (0.1mg) and Ku70/80 (0.05mg) were incubated with increasing amounts of CT DNA (lanes 1–3) or hTR
(lanes 4–6) under kinase assay conditions as described in ‘Materials and Methods’ section. The reactions were analyzed by SDS–PAGE and
autoradiography. The positions of the phosphorylated DNA-PK subunits are indicated. (B) DNA-PK phosphorylates puriﬁed recombinant
hnRNP A1 but not hnRNP A2 in vitro. GST-hnRNP A1 and A2 were puriﬁed over GST-Sepharose as described in ‘Materials and Methods’
section. Puriﬁed DNA-PKcs (0.1mg) and Ku70/80 (0.05mg) were incubated alone (lanes 1–3), with 1mg GST hnRNP A1 (lanes 4–6) or with 1mg GST
hnRNP A2 (lanes 7–9) under kinase assay conditions in the presence of TE, CT-DNA (0.5mg) or hTR (0.5mg), respectively. The reactions were
fractionated by SDS–PAGE and Coomassie stained gels (left panel, labeled as Gel) were dried and exposed to X-ray ﬁlm (right panel, labeled
Autorad). The positions of the autophosphorylated DNA-PKcs and phosphorylated GST-hnRNP A1 are indicated. (C) Phosphorylation of hnRNP
A1 by DNA-PK is ablated in the presence of RNase A but not DNase 1. DNA-PK assays with GST-hnRNP A1 were carried out with CT-DNA
(lanes 1–3) or hTR (lanes 4–6) in the presence of RNase A (0.25mg/ml, lanes 3 and 6) or DNase 1 (0.1U/ml, lanes 2 and 5) under standard conditions.
The reactions were fractionated on SDS–PAGE and analyzed by autoradiography. The upper panel shows the X-ray ﬁlm (Autorad) and the lower
panel the corresponding region of the stained gel of GST-hnRNP A1 (Gel).
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in the presence of Ku, hnRNP A1 and hTR was not seen
with the hTR (404–451) probe.
To conﬁrm the presence of Ku and hnRNP A1 in com-
plex ‘c’ with FL-hTR, the EMSA gel was transferred onto
PVDF membrane, and analyzed by western blotting. As
seen in Figure 5B, monoclonal antibodies to Ku and
hnRNP A1 indicated the presence of Ku (right panel,
lanes 5 and 6) and hnRNP A1 (left panel, lanes 5 and
6), respectively. Collectively, these data suggest that
hnRNP A1 and Ku bind the same hTR molecule, possibly
at the 50 and 30 ends, respectively.
To extend these studies to a cellular context, we
performed immunoprecipitation studies with extracts
prepared from either HeLa cells, which are telomerase
positive and express hTR, or VA-13 cells which are
SV40 transformed human lung ﬁbroblasts that lack
detectable hTR and hTERT and maintain their telomeres
by the ALT pathway (46). Western blots of complexes
from immunoprecipitation with a monoclonal antibody
to Ku indicated the presence of both Ku and hnRNP
A1 in both cell lines. Immunoprecipitates from reciprocal
immunoprecipitation assays using a monoclonal anti-
body to hnRNP A1 also contained Ku and hnRNP A1
(Figure 6). Therefore, these data suggest that Ku interacts
with hnRNP A1 in cells independent of hTR. This inter-
action may be direct or mediated by addition factors in
cells. It appears however, that the interaction between Ku
and hnRNP A1 is not suﬃcient to support eﬃcient phos-
phorylation of hnRNP A1 in the absence of hTR.
Moreover, although Ku70/80 and hnRNP A1 can interact
in the absence of hTR, we speculate that the binding of
each protein with the telomerase RNA is necessary to
activate DNA-PKcs for the phosphorylation hnRNP A1
(see below).
Identification of in vitro and in vivo DNA-PK
phosphorylation sites on hnRNP A1
DNA-PK preferentially targets Ser/Thr followed by a Gln
residue (S/T-Q motifs) (5). To date, hnRNP A1 has been
shown to be phosphorylated on Ser 192 and Ser 310–312
by Map Kinase interacting kinases (MNKs) during the
activation of T-cells (47). As an initial step toward eluci-
dating the importance of hnRNP A1 phosphorylation, we
wanted to identify which amino acid residues are targeted
by DNA-PK. Examination of the amino acid sequence
of hnRNP A1 revealed two DNA-PK consensus
phosphorylation sites at Ser 95 and Ser 192 (Figure 2).
These residues are highly conserved between mouse and
human. Moreover, in the closely related protein hnRNP
A2, which is not a substrate for DNA-PK (Figure 1B),
these Ser residues are not followed by Gln. We therefore
reasoned that these two sites were excellent candidates for
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Figure 3. Speciﬁcity of hnRNP A1 phosphorylation by DNA-PK. (A)
hTR does not support DNA-PK-mediated phosphorylation of XRCC4
or Artemis. DNA-PK kinase assays were performed with puriﬁed
recombinant GST-XRCC4 (1.0mg, lanes 1 and 2) or GST-Artemis
(1.0mg, lanes 3 and 4) in the presence of CT-DNA (lanes 1 and 3) or
hTR (lanes 2 and 4). The Coomassie stained gel is shown on the left
panel (Gel), and the corresponding autoradiogram is shown in the
right panel (Autorad). The migrating position of GST-XRCC4 and
GST-Artemis are indicated by ‘ ’ and ‘+’, respectively. (B) Nucleic
acid requirements for hnRNP A1 phosphorylation by DNA-PK.
Kinase reactions with DNA-PK and GST-hnRNP A1 were performed
in the presence of TE (lane 1) or 0.5mg each of CT-DNA (lane 2), hTR
(lane 3), Oligo(dT) (lane 4), poly(AU) (lane 5), poly(G) (lane 6), or
tRNA (lane 7). The upper panel represents the X-ray ﬁlm (Autorad)
showing the phosphorylated GST-hnRNP A1 and the bottom panel is
the corresponding region of the Coomassie stained gel for GST-hnRNP
A1 (Gel). (C) DNA- and hTR-dependent phosphorylation of hnRNP
A1 by DNA-PK is inhibited by the DNA-PK inhibitor NU7441. DNA-
PK kinase reactions with GST-hnRNP A1 and CT DNA (lanes 1–4) or
hTR (lanes 5–8) were carried out with increasing concentrations (lanes
1–4 and lanes 5–8; 0, 0.02, 0.05, 0.1mM, respectively) of the speciﬁc
DNA-PK kinase inhibitor NU4771. The autoradiogram is featured in
the upper panel (Autorad), and the corresponding Coomassie stained
gel for GST-hnRNP A1 is shown in the lower panel (Gel).
Human hnRNP A1 89AVSREDSQRPGAHL102         86 EMASASSSQRGRSGSG200   
Human hnRNP A2         AVAREESGKPGAHV                EMQEVQSSRSGRGGNF
Mouse hnRNP A1          AVSREDSQRPGAHL                EMASASSSQRGRSGSG  
95 192
Figure 2. Comparison of the amino acid sequences of mouse hnRNP
A1, human hnRNP A1 and hnRNP A2. Putative DNA-PK phosphor-
ylation sites, Serine 95 and Serine 192, are represented by bold letters.
Both residues are present in all three amino acid sequences shown,
however, in hnRNP A1, but not hnRNP A2, Serine 95 and Serine
192 (of hnRNP A1) are followed by a Glutamine (Q) residue. The
Genbank accession numbers are as follows: mouse hnRNP A1–
P49312; human hnRNP A1-P09651; human hnRNP A2–BAA06032.
6110 Nucleic Acids Research, 2009, Vol. 37,No. 18DNA-PK phosphorylation. Based on these observations,
we generated GST hnRNP A1 proteins harboring either
a single Ser to Ala mutation at Ser 95 (S95A) and Ser 192
(S192A) or the double mutation at both Ser 95 and Ser
192 (S95/192A). These mutant proteins were expressed as
GST-recombinant proteins, puriﬁed and tested in
DNA-PK assays in vitro in the presence of CT DNA or
hTR (Figure 7). In the presence of either CT DNA or
hTR, when compared to the WT, phosphorylation
was reduced by 39% in the single S95A mutant (compare
lanes 5 and 6 to lanes 2 and 3); however, phosphorylation
was not signiﬁcantly reduced the S192A mutant (data
not shown). In contrast, DNA-PK phosphorylation was
reduced by 69% in the double S95/192A mutant hnRNP
A1 (compare lanes 8 and 9 to lanes 2 and 3, Figure 7). We
speculate that phosphorylation of Ser-95 and Ser-192 by
B
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(lane 1), or with 0.2 and 0.4pmol of puriﬁed Ku70/80 (lanes 2 and 3)
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fragment constituting nucleotides 404–451. The position of migration
of the Ku-hTR 404–451 complex is indicated by the arrow. (B) Western
blot analysis of EMSA of FL-hTR with Ku and hnRNP A1. An EMSA
gel containing the following combinations of FL-hTR and/or puriﬁed
Ku and GST-hnRNP A1 was transferred directly to PVDF membrane
and western blotted with monoclonal antibodies against hnRNP A1 (left
panel) or Ku70/80 (right panel). Lane 1, 10pmol of GST-hnRNP
A1 alone; lane 2, 0.2pmol of Ku alone; lane 3, 0.3pmol of FL-hTR
with 10pmol of GST-hnRNP A1; lane 4, FL-hTR with 0.2pmol of Ku;
lanes 5 and 6, FL-hTR, 0.2pmol of Ku with 10 and 20pmol of GST-
hnRNPA1, respectively. The hTR–protein complexes, as described
above, are indicated by letters ‘a’, ‘b’ and ‘c’.
A
Autorad
Gel
1
–
3
5
4
4
0
4
–
4
5
1
1
–
4
5
1
3
5
4
–
4
5
1
1
–
1
5
9
C
T
-
D
N
A
T
E
hTR
1       2      3 4     5       6      7
GST-hnRNP A1 
GST-hnRNP A1 
B
1
–
3
5
4
4
0
4
–
4
5
1
1
–
4
5
1
3
5
4
–
4
5
1
1
–
3
5
4
 
+
3
5
4
–
4
5
1
1
–
3
5
4
 
+
4
0
4
–
4
5
1
1        2        3    4        5       6
Autorad
Gel
GST-hnRNP A1 
GST-hnRNP A1 
hTR
C hTR “denatured” hTR
GST-hnRNP A1 
1      2      3      4    5     6     7      8
Autorad
GST-hnRNP A1  Gel
Figure 4. hTR stimulates DNA-PK mediated phosphorylation of
hnRNP A1. (A) hTR requirements for hnRNP A1 phosphorylation
by DNA-PK. DNA-PK reactions with GST-hnRNP A1 were carried
out in the presence of TE control (lane 1), 0.5mg of CT-DNA (lane 2),
0.5mg each of FL-hTR (lane 3) or diﬀerent fragments of hTR (lanes 4–
7) as indicated on the top of the Autorad panel. (B) FL-hTR is
required for eﬃcient hnRNP A1 phosphorylation by DNA-PK.
DNA-PK reactions with GST-hnRNP A1 were performed in the
presence of 30pmol of FL-hTR (lane 1), or diﬀerent fragments of
hTR (lane 2, 1–354; lane 3, 354–451; lane 4, 404–451) or equimolar
amounts of diﬀerent combinations of hTR fragments as indicated on
the top of the Autorad panel (lanes 5 and 6). (C) Heat-denatured hTR
cannot stimulate phosphorylation of hnRNP A1. DNA-PK reactions
with GST-hnRNP A1 were performed with increasing concentrations of
full-length untreated hTR (lanes 1–4), or heat-denatured hTR (lanes
5–8). The amounts of hTR used were 0.1, 0.2, 0.5, 1.0mg (lanes 1–4
and lanes 5–8, respectively). In each ﬁgure, the autoradiogram is in the
upper panel, and the region of the Coomassie stained gel corresponding
to GST-hnRNP A1 (Gel) is shown in the bottom panel.
Nucleic Acids Research, 2009,Vol.37, No. 18 6111DNA-PK might be coordinately regulated, such that elim-
ination of Ser-192 might enhance phosphorylation at Ser-
95. Alternatively, mutation of both Ser-95 and Ser-192
might induce a conformational change that reduces the
ability of DNA-PK to target hnRNP A1. Regardless,
these data are the ﬁrst to report the phosphorylation of
hnRNP A1 at Ser 95, and also suggests that DNA-PK
may target Ser-192.
hnRNP A1 is phosphorylated in a DNA-PK-dependent
manner in vivo
In order to determine if hnRNP A1 is an in vivo sub-
strate for DNA-PK, we cultured HeLa cells with
32P-inorganic phosphate in the presence or absence of
DNA-PK inhibitors (wortmannin or NU4771) for 4h
and prepared cell extracts for immunoprecipitation with
anti-hnRNP A1 antibodies. As seen in Figure 8A,
32P
incorporation into hnRNP A1 was reduced in hnRNP
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Figure 8. hnRNP A1 is phosphorylated in vivo and phosphorylation
is inhibited by the DNA-PK and PIKK inhibitors, NU4771 and
wortmannin. (A) HeLa cells were incubated in phosphate-free
medium in the presence of DMSO (lanes 1 and 2), wortmannin
(5mM, lane 3) or the DNA-PK inhibitor NU7441 (10mM, lane 4) as
described in ‘Materials and Methods’ section. Inorganic
32P-phosphate
was then added to the media, and the cells were further cultured
for 4h. Extracts were immunoprecipitated with control monoclonal
IgG antibodies (lane 1) or antibodies to hnRNP A1 (lanes 2–4). The
immune-complexes were fractionated on SDS–PAGE, transferred
onto PVDF membrane, and exposed to X-ray ﬁlm, before western
blot analysis. The top panel shows the western blot for hnRNP
A1 and the middle panel shows the resulting autoradiogram. The inten-
sity of the
32P incorporation in the immunoprecipitated hnRNP
A1 lanes was quantiﬁed using Quantity One software (Biorad) and
expressed as a percentage compared to the control (lane 2). (B) Cells
were mock-transfected (HeLa, lane 2), transfected with control
plasmid pU3–500 (HeLa, lane 3 and VA13, lane 4), or transfected
with pU3-hTR-500 (VA13, lane 5 and 6) for 48h as described in
‘Materials and Methods’ section. The cells were then incubated with
DMSO (lanes 2–5) or with 10mM NU4771 (lane 6) and metabolic
labeling with
32P-inorganic phosphate was carried out as in panel A.
Extracts were made for immunoprecipitations with control monoclonal
IgG antibodies (lane 2) or antibodies to hnRNP A1 (lanes 3–6). The
immune-complexes were fractionated on SDS–PAGE, and transferred
onto PVDF membrane, and exposed to X-ray ﬁlm, before western
blot analysis. Parallel cell cultures treated the same way but grown
without
32P-inorganic phosphate were isolated for RNA preparation
and RT–PCR analysis as described in ‘Materials and Methods’ section.
The contents of each lane are indicated at the top of the panels. The
top panel shows the western blot for hnRNP A1, the middle panel
shows the resulting autoradiogram, and the bottom panel shows
the RT–PCR reaction for hTR. Lane 1 represents non-template PCR
reaction control.
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Figure 7. Identiﬁcation of phosphorylation sites on hnRNP A1. GST-
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top panel. The intensity of the
32P incorporation in each of the phos-
phorylation mutant GST-hnRNP A1 proteins was quantiﬁed using
Quantity One software (Biorad) and expressed as a percentage
compared to phosphorylation of WT (lanes 2 and 3, shown in the
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wortmannin or NU4771 compared to the control
cell extracts (bottom panel, compare lanes 3 and 4 to
lane 2). Although signiﬁcantly reduced in the presence
of NU4771, hnRNP A1 phosphorylation was not com-
pletely abolished, suggesting that other protein kinases
may play a role in the phosphorylation of this protein
in vivo. Regardless, this observation strongly suggests
that hnRNP A1 is a physiological substrate for DNA-PK.
Next, we looked at the phosphorylation of hnRNP
A1 in WI38-VA13 cells. hnRNP A1 immunoprecipitated
from VA13 cells showed reduced
32P-incoporation com-
pared to hnRNP A1 immunoprecipitated from HeLa
cells (Figure 8B, compare lanes 3 to 4, middle panel).
Phosphorylation of hnRNP A1 was increased to levels
comparable to those seen in HeLa cells when hnRNP
A1 was immunoprecipitated from VA13 cells exogenou-
sly expressing hTR (Figure 8B, compare lanes 5 to 3). This
enhanced phosphorylation of hnRNP A1 in VA13 cells
expressing hTR was inhibited by NU4771 (Figure 8B,
lane 6), suggesting that this eﬀect was mediated through
DNA-PK. Together these data strongly suggest that
hnRNP A1 is phosphorylated by DNA-PK in a hTR-
dependent manner in vivo.
DISCUSSION
We have previously shown that Ku70/80 interacts with
the RNA component of human telomerase, hTR. To elu-
cidate the functional signiﬁcance of this interaction, we
examined whether or not this interaction could activate
DNA-PK activity. In this study, we show that both hTR
and DNA stimulate DNA-PK kinase activity towards the
novel substrate, hnRNP A1. Our EMSA results suggest
that hnRNP A1 and Ku70/80 can interact on the same full
length, intact hTR molecule. Furthermore, we observed
that Ku and hnRNP A1 were found in the same complex
in immunoprecipitates from cellular extracts. Treatment
of cells with the highly speciﬁc DNA-PK inhibitor
NU7441 resulted in reduced hnRNP A1 phosphorylation.
Furthermore, in VA13 cells that lack hTR, phosphoryl-
ation of hnRNP A1 was greatly reduced and was restored
by exogenous expression of the telomerase RNA.
Together, these data strongly suggest that hnRNP A1 is
a physiological substrate for DNA-PK. As an initial step
towards understanding the functional signiﬁcance of this
phosphorylation event, we identiﬁed Ser 95 and Ser 192 on
hnRNP A1 as potential phosphorylation sites for DNA-
PK in vivo and in vitro.
Phosphorylation of hnRNP A1 has been reported to
inﬂuence many of its cellular functions. In response to
an inﬂammatory signal, hnRNP A1 is phosphorylated
by MNK1 at Ser 192 and Ser cluster at Ser 310–312 in
Jurkat T cells; this phosphorylation event negatively
regulates binding of hnRNP A1 to the AU rich element
(ARE) in the 30UTR of the tumor necrosis factor alpha
(TNF-a) mRNA, reducing expression of TNFa (47).
Similarly, cells stressed by osmotic shock, show accumu-
lation of hnRNP A1 to cytoplasmic granules that is
dependent on hnRNP A1 phosphorylation on Ser 192
by the MAP p38 kinase cascade (48). It is currently
unknown whether phosphorylation or other types of
post-translational modiﬁcations of hnRNP A1 contribute
to its function in telomere length maintenance. To our
knowledge, this is the ﬁrst report of direct hnRNP A1
phosphorylation by DNA-PK at a novel in vitro and
in vivo site, Ser 95. We have also identiﬁed Ser 192 as a
potential in vitro and in vivo DNA-PK phosphorylation
site. We speculate that phosphorylation of hnRNP A1
by DNA-PK could aﬀect the function of hnRNP A1 at
telomeres, independent of its splicing function.
Although it has been previously demonstrated that
poly(G) RNA can stimulate the protein kinase activity
of DNA-PK in vitro, to our knowledge, this is the ﬁrst
demonstration that a physiological, structured RNA
molecule (hTR) can activate DNA-PK in vitro and in
cells. Speciﬁcally, we show that, in the presence of hTR,
DNA-PK is able to phosphorylate hnRNP A1, a protein
known to be involved in telomere length maintenance.
Furthermore, we show that this hTR stimulation is spe-
ciﬁc for hnRNP A1, in that other DNA-PK substrates,
namely XRCC4 and Artemis, are only weakly phosphor-
ylated in the presence of hTR. It is also interesting to note
that hnRNP A2, a protein very closely related to hnRNP
A1, is not phosphorylated by DNA-PK. With respect to
its function in splicing, hnRNP A2 is thought to be redun-
dant with hnRNP A1, however, hnRNP A2 cannot over-
come the hnRNP A1 deﬁciency and telomere length
defects in erythroleukemic cell lines (25). One possible
explanation for the inability of hnRNP A2 to function
at telomeres might be that phosphorylation of hnRNP
A1 at speciﬁc sites by DNA-PK is required for its role
in telomere length maintenance. In addition, although
Ku and hnRNP A1 can interact in cells lacking hTR,
this interaction is not suﬃcient to stimulate phosphoryl-
ation of hnRNPA1 by DNA-PK since VA13, cells which
lack hTR, have signiﬁcantly reduced levels of hnRNP A1
phosphorylation and this phosphorylation is signiﬁcantly
increase upon the exogenous expression of hTR. Together,
these data suggest that in vivo, hTR is required for the
phosphorylation of hnRNP A1 by DNA-PK.
It is interesting to note that in vitro, DNA-mediated
autophosphorylation of DNA-PKcs is associated with
loss of protein kinase activity and dissociation of the
DNA-PK complex (5,49,50). Moreover, cells expressing
DNA-PKcs that lack multiple in vitro autophos-
phorylation sites are radiosensitive and defective in DSB
repair (51). Together, these studies suggest that upon
interaction with DSBs, DNA-PK becomes activated and
subsequently undergoes autophosphorylation induced
inactivation (5). Our in vitro results showing that DNA-
PK can be activated by hTR without undergoing auto-
phosphorylation suggests the possibility that DNA-PK
may be regulated diﬀerently at telomeres than at DSBs.
These data suggest that hTR might stimulate DNA-PK
phosphorylation of telomere associated proteins in the
absence of a DSB without inactivating its kinase activity
and/or releasing DNA-PKcs from the telomere.
In yeast, the association of TLC1 with Ku70/80 is
crucial to recruit the telomerase components, Est1p
and Est2p to telomeres for telomerase synthesis during
Nucleic Acids Research, 2009,Vol.37, No. 18 6113S-phase (19). However, since yeast do not contain DNA-
PKcs, the function of Ku at telomeres may be subtly
diﬀerent between humans and yeast. Whether or not the
hTR/Ku interaction in human cells serves to recruit tel-
omerase components to telomeres or serves another crit-
ical function in cells remains to be explored. Nevertheless,
based on the data presented here we speculate that the
interaction of Ku and hnRNP A1 with hTR during telo-
mere synthesis could recruit DNA-PKcs to phosphorylate
hnRNP A1 and regulate its function during telomere
synthesis. We speculate that phosphorylation of hnRNP
A1 could inﬂuence its ability to recruit telomerase to
chromosome ends or modulate higher order telomere
structures. Studies to address the function of hnRNP A1
phosphorylation mutants at telomeres are ongoing.
Unlike hTERT and telomerase activity, which are only
present in germ cells, stem cells and cells with a high pro-
liferative index, hTR is ubiquitously expressed in somatic
cells (52). It is therefore very likely that hTR has other, yet
to be discovered roles, in the cell. We suggest that in add-
ition to its critical role in directing telomere addition by
telomerase, hTR may act as a co-factor for DNA-PK to
phosphorylate proteins that are involved in telomere
length maintenance. Consistent with additional roles for
hTR in cells, hTR levels increase irrespective of telomerase
status in response to low levels of UV radiation (53).
Consequently, the elevated levels of hTR attenuate the
activity of ATR, a PIKK family member related to
DNA-PKcs, and facilitate cellular recovery of cells from
UV radiation (53). Interestingly DNA-PK interacts with,
and is targeted by ATR in response to UV exposure,
implicating DNA-PK in the same damage pathway (54).
Together, these observations lead to the intriguing pos-
sibility that hTR may be used as a signaling molecule
in response to UV-induced DNA damage to regulate the
activities of DNA-PK and ATR, in a manner that is inde-
pendent of its telomere templating function.
In summary, we have shown that DNA-PK phos-
phorylates hnRNP A1 in an hTR-dependent manner
in vitro and that hTR is important for the phosphorylation
of hnRNP A1 by DNA-PK in cells. These results reveal
a novel property for DNA-PK, namely, the ability of a
physiologically relevant RNA molecule, hTR, to activate
its kinase activity. Moreover, since the kinase activity of
DNA-PK is required for telomere function (16) we spec-
ulate that the hTR-dependent-phosphorylation of hnRNP
A1 might play a critical role in telomere function in vivo.
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